Trials / Conditions / Non-Hodgkin
Non-Hodgkin
6 registered clinical trials studyying Non-Hodgkin — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | AZD3470 as Monotherapy and in Combination With Anticancer Agents in Participants With Relapsed/Refractory Haem NCT06137144 | AstraZeneca | Phase 1 / Phase 2 |
| Unknown | Tenofovir to Prevent HBV Reactivation NCT02186574 | University Health Network, Toronto | Phase 3 |
| Completed | Observational Study in Participants With Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma (MM) and Non-Hod NCT02559583 | Janssen-Cilag Ltd. | — |
| Completed | SAR3419 Administered Weekly in Patients With Relapsed/Refractory CD19-positive B-cell Non-Hodgkin's Lymphoma NCT00796731 | Sanofi | Phase 1 |
| Completed | Multi-dose-escalation Safety and Pharmacokinetic Study of SAR3419 as Single Agent in Relapsed/Refractory B-cel NCT00549185 | Sanofi | Phase 1 |
| Completed | A Phase I Study of the Chimeric Anti-CD40 Monoclonal Antibody ChiLob 7/4 to Treat Advanced Malignancies Refrac NCT01561911 | Cancer Research UK | Phase 1 |